Insider filing · CRSP
Simeon George
Director
profile →
CRISPR Therapeutics AG
CRSP · Healthcare · 39 filings in 24 months
ticker →
Simeon George sold $720K of CRISPR Therapeutics AG (CRSP)
Executed Oct 14, disclosed Oct 16, 2 days later.
Value, as filed
$720K
14,514 sh × $49.63
Executed
Oct 14
the trade date, as filed
Disclosed
Oct 16
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SGSimeon George (Director) filed 2 Form 4 reports in the trailing twelve months (1 purchase, 1 sale), most often in CRISPR Therapeutics AG (CRSP). Across 1 priced purchase filing, the average 21-session return was -6.3% from execution and -8.9% from disclosure (delay-adjusted; derived). The largest single filing was $27.2M of ADRX (1,600,000 sh across 3 lots, as filed), executed Sep 28.
The name
CRSPHealthcare · CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered R…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Simeon George in CRSP
CRSPPURCHASE
CRISPR Therapeutics AG
$51.5M989,812 sh across 3 lots
Exec Jul 16 2025
Filed Jul 17 2025 · 5:19 PM ET